Access cutting-edge obesity treatment through this clinical trial at a research site in Fort Lauderdale. Study-provided care at no cost to qualified participants.
Access obesity specialists in Fort Lauderdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related obesity treatment provided free
The purpose of this Master Protocol is to support two studies to see how well and how safely orforglipron works compared to placebo in participants who have obesity or overweight with or without type 2 diabetes. Participants will be screened for about 4 weeks, after which they will enroll into either J2A-MC-GZP1, NCT06972459 (do not have type 2 diabetes) or J2A-MC-GZP2, NCT06972472 (have type 2 diabetes).
Sponsor: Eli Lilly and Company
Check if you qualify for this obesity clinical trial in Fort Lauderdale, FL
If you're searching for obesity treatment options in Fort Lauderdale, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fort Lauderdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.